Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist.
Domenico AlbanoGiovanni BosioDavide TomasiniMarco BonùRaffaele GiubbiniFrancesco BertagnaPublished in: Asia-Pacific journal of clinical oncology (2020)
An 82% rate of PET avidity in GIST was found and it was correlated with stage, tumor risk group and mitotic index. Only baseline 18 F-FDG-avidity, MTV and TLG were independently correlated with PFS.